CHFS stock forecast
Our latest prediction for CHF Solutions, Inc.'s stock price was made on the March 12, 2019 when the stock price was at 4.34$.
In the short term (2weeks), CHFS's stock price should outperform the market by 4.64%. During that period the price should oscillate between -13.15% and +24.76%.
In the medium term (3months), CHFS's stock price should underperform the market by -2.03%. During that period the price should oscillate between -26.86% and +59.44%.Get email alerts
About CHF Solutions, Inc.
CHF Solutions, Inc. is a medical device company, which engages in the provision of products for the treatment of fluid overload. Its product include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
At the moment the company generates 5M USD in revenues.
On its last earning announcement, the company reported a loss of -42.12$ per share.
The book value per share is 1.25$
Three months stock forecastMarch 12, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|